Tactile Systems Technology (FRA:3L3) ROCE %: -1.49% (As of Mar. 2026)

What is Tactile Systems Technology ROCE %?

Tactile Systems Technology FRA:3L3 -0.53% 76 ROCE % is -1.49% as of Mar. 2026. GuruFocus rates FRA:3L3 with a GF Score™ of 76/100 and a GF Value™ of €16.59 (Significantly Overvalued). The stock has 3 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Tactile Systems Technology's annualized ROCE % for the quarter that ended in Mar. 2026 was -1.49%.

Tactile Systems Technology (FRA:3L3) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Tactile Systems Technology ROCE % Related Terms

Tactile Systems Technology ROCE % Historical Data

* Premium members only.

The historical data trend for Tactile Systems Technology's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tactile Systems Technology ROCE % Chart

Tactile Systems Technology Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

ROCE %

Get a 7-Day Free Trial

-1.02

-6.55

9.12

10.48

12.44

Tactile Systems Technology Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
ROCE %	Get a 7-Day Free Trial															-5.72	7.99	20.37	34.41	-1.49

76GF Score

Tactile Systems Technology Inc FRA:3L3

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Tactile Systems Technology ROCE % Calculation

Tactile Systems Technology's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	27.65	/	( ( (284.517 - 38.872)	+	(233.946 - 34.977) )	/ 2 )
	=	27.65	/	( (245.645	+	198.969)	/ 2 )
	=	27.65	/	222.307
	=	12.44 %

Tactile Systems Technology's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	-3.004	/	( ( (233.946 - 34.977)	+	(235.38 - 31.15) )	/ 2 )
	=	-3.004	/	( ( 198.969	+	204.23 )	/ 2 )
	=	-3.004	/	201.5995
	=	-1.49 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of -1.49% mean?

Tactile Systems Technology (FRA:3L3) has a ROCE % of -1.49% as of Mar. 2026.

Is Tactile Systems Technology's ROCE % too high?

Tactile Systems Technology's current ROCE % is -1.49%. Overall, Tactile Systems Technology has a GF Score™ of 76/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Tactile Systems Technology's ROCE % compare to SSII and BVS?

Tactile Systems Technology's ROCE % of -1.49% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.20. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Medical Devices & Instruments company?

The median ROCE % among Medical Devices & Instruments companies is 2.20, based on 813 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tactile Systems Technology's current ROCE % is -1.49%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Tactile Systems Technology stock overvalued right now?

Based on GuruFocus' analysis, Tactile Systems Technology (FRA:3L3) is currently considered Significantly Overvalued. The stock's GF Value™ is €16.59, compared to a current price of €26.42 — trading 59.3% above its estimated fair value. The current ROCE % is -1.49%. Tactile Systems Technology's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For Tactile Systems Technology (FRA:3L3), the current ROCE % is -1.49% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tactile Systems Technology (FRA:3L3) Overvalued in 2026?

Based on GuruFocus' analysis, Tactile Systems Technology stock appears to be overvalued. The current stock price of €26.42 is trading 59.3% above its estimated GF Value™ of €16.59. GuruFocus considers Tactile Systems Technology to be Significantly Overvalued.

Key valuation signals for FRA:3L3:

ROCE %: -1.49%
GF Value™: €16.59 vs. price of €26.42 (59.3% above fair value)
GF Score™: 76/100 with 3 warning signs

No single metric tells the full story. See the FRA:3L3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tactile Systems Technology Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies SSII BVS BBNX CBLL SIBN CERS CTKB NPCE CLPT INMD ABT SYK MDT BSX EW XTER:SHL GEHC DXCM XAMS:PHIA SZSE:300760

Other Exchanges TCMD:USA 3L3:Germany

Address 3701 Wayzata Boulevard, Suite 300, Minneapolis, MN, USA, 55416

Website https://www.tactilemedical.com

Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system, provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.

76GF Score

Get the complete analysis for FRA:3L3

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€26.42

Price

€16.59

GF Value

View FRA:3L3 Analysis

See ROCE % data for all stocks →